Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer genomics.

P E Li1, P S Nelson

  • 1Division of Human Biology, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Mailstop D4-100, Seattle, WA 98109-1024, USA. pli@u.washington.edu

Current Urology Reports
|June 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LSD1 inhibition suppresses ASCL1 and de-represses YAP1 to drive potent activity against neuroendocrine prostate cancer.

bioRxiv : the preprint server for biology·2024
Same author

In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo.

Nature communications·2020
Same author

Reply by Authors.

The Journal of urology·2020
Same author

Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Systematic and functional characterization of novel androgen receptor variants arising from alternative splicing in the ligand-binding domain.

Oncogene·2016
Same author

A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment.

Prostate cancer and prostatic diseases·2016
Same journal

Effective Mentorship in Urology Fellowship Training: Qualities, Models, and Equity.

Current urology reports·2026
Same journal

Management of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis.

Current urology reports·2026
Same journal

Lower Urinary Tract Symptoms as an Indicator of Occult Neurologic Disease: A System-first Framework for Urologic Practice.

Current urology reports·2026
Same journal

Association Between Ambient Temperature and Urolithiasis: A Systematic Review and Meta-analysis.

Current urology reports·2026
Same journal

Is Open Partial Nephrectomy Still an Option in the Robotic Era?

Current urology reports·2026
Same journal

Artificial Intelligence in Urologic Documentation: A Review of Emerging Capabilities and the Ongoing Need for Human Oversight.

Current urology reports·2026
See all related articles

Investigating prostate cancer involves studying genetic changes and molecular pathways. New technologies like DNA sequencing and microarrays offer a comprehensive view for developing targeted therapies.

Area of Science:

  • Molecular biology
  • Genetics
  • Cancer research

Background:

  • Prostate cancer development involves complex molecular processes.
  • Understanding genetic alterations and signaling pathways is crucial for cancer research.
  • A holistic cellular view is needed to grasp tumorigenesis.

Purpose of the Study:

  • To investigate the molecular processes underlying prostate cancer.
  • To explore methods for discovering genetic alterations in prostate neoplasia.
  • To identify potential therapeutic targets for prostate cancer.

Main Methods:

  • Family studies to map hereditary disease loci.
  • Chromosomal studies to identify oncogenes and tumor suppressor genes.
  • Comprehensive gene expression studies and new biotechnologies (automated DNA sequencing, cDNA microarrays).

Related Experiment Videos

Main Results:

  • Various molecular signaling pathways influence or reflect carcinogenesis.
  • Integration of computers, miniaturization, and automation aids in understanding complex biological systems.
  • Biotechnologies provide a systematic, discovery-driven approach to cancer research.

Conclusions:

  • New biotechnologies offer a comprehensive view of biology and pathology.
  • These technologies have the potential to fully characterize neoplasia processes.
  • This comprehensive understanding can lead to potential therapeutic targets for prostate and other cancers.